These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

608 related articles for article (PubMed ID: 25003359)

  • 101. [Fingolimod treatment for multiple sclerosis patients. Infectiological aspects and recommendations for vaccinations].
    Winkelmann A; Löbermann M; Reisinger EC; Zettl UK
    Nervenarzt; 2012 Feb; 83(2):236-42. PubMed ID: 21845450
    [TBL] [Abstract][Full Text] [Related]  

  • 102. Matrix metalloproteinase-9 concentration after spontaneous intracerebral hemorrhage.
    Abilleira S; Montaner J; Molina CA; Monasterio J; Castillo J; Alvarez-Sabín J
    J Neurosurg; 2003 Jul; 99(1):65-70. PubMed ID: 12854746
    [TBL] [Abstract][Full Text] [Related]  

  • 103. Tumefactive demyelination and a malignant course in an MS patient during and following fingolimod therapy.
    Hellmann MA; Lev N; Lotan I; Mosberg-Galili R; Inbar E; Luckman J; Fichman-Horn S; Yakimov M; Steiner I
    J Neurol Sci; 2014 Sep; 344(1-2):193-7. PubMed ID: 25001515
    [TBL] [Abstract][Full Text] [Related]  

  • 104. Extent of secondary intraventricular hemorrhage is an independent predictor of outcomes in intracerebral hemorrhage: data from the Helsinki ICH Study.
    Mustanoja S; Satopää J; Meretoja A; Putaala J; Strbian D; Curtze S; Haapaniemi E; Sairanen T; Niemelä M; Kaste M; Tatlisumak T
    Int J Stroke; 2015 Jun; 10(4):576-81. PubMed ID: 25580771
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Ketoconazole increases fingolimod blood levels in a drug interaction via CYP4F2 inhibition.
    Kovarik JM; Dole K; Riviere GJ; Pommier F; Maton S; Jin Y; Lasseter KC; Schmouder RL
    J Clin Pharmacol; 2009 Feb; 49(2):212-8. PubMed ID: 19118083
    [TBL] [Abstract][Full Text] [Related]  

  • 106. Targeted temperature management after intracerebral hemorrhage (TTM-ICH): methodology of a prospective randomized clinical trial.
    Rincon F; Friedman DP; Bell R; Mayer SA; Bray PF
    Int J Stroke; 2014 Jul; 9(5):646-51. PubMed ID: 24450819
    [TBL] [Abstract][Full Text] [Related]  

  • 107. FTY720 reduces inflammation and promotes functional recovery after spinal cord injury.
    Lee KD; Chow WN; Sato-Bigbee C; Graf MR; Graham RS; Colello RJ; Young HF; Mathern BE
    J Neurotrauma; 2009 Dec; 26(12):2335-44. PubMed ID: 19624262
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Reassessment of defibrase in treatment of acute cerebral infarction: a multicenter, randomized, double-blind, placebo-controlled trial.
    Cooperative Group for Reassessment of Defibrase
    Chin Med Sci J; 2005 Sep; 20(3):151-8. PubMed ID: 16261883
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Outcomes of switching directly to oral fingolimod from injectable therapies: Results of the randomized, open-label, multicenter, Evaluate Patient OutComes (EPOC) study in relapsing multiple sclerosis.
    Fox E; Edwards K; Burch G; Wynn DR; LaGanke C; Crayton H; Hunter SF; Huffman C; Kim E; Pestreich L; McCague K; Barbato L;
    Mult Scler Relat Disord; 2014 Sep; 3(5):607-19. PubMed ID: 26265273
    [TBL] [Abstract][Full Text] [Related]  

  • 110. Reduced Intracerebral Hemorrhage and Perihematomal Edema Volumes in Diabetics on Sulfonylureas.
    Irvine H; Male S; Robertson J; Bell C; Bentho O; Streib C
    Stroke; 2019 Apr; 50(4):995-998. PubMed ID: 30879436
    [TBL] [Abstract][Full Text] [Related]  

  • 111. Association between seizures and outcomes among intracerebral hemorrhage patients: the China National Stroke Registry.
    Li Z; Zhao X; Wang Y; Wang C; Liu L; Shao X; Wang W; Pan Y; Wang C; Ji R; Zhang C; Jing J; Wang Y
    J Stroke Cerebrovasc Dis; 2015 Feb; 24(2):455-64. PubMed ID: 25511617
    [TBL] [Abstract][Full Text] [Related]  

  • 112. Quantitative Intracerebral Hemorrhage Localization.
    Muschelli J; Ullman NL; Sweeney EM; Eloyan A; Martin N; Vespa P; Hanley DF; Crainiceanu CM
    Stroke; 2015 Nov; 46(11):3270-3. PubMed ID: 26451031
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Functional Long-Term Outcome after Left- versus Right-Sided Intracerebral Hemorrhage.
    Beuscher VD; Kuramatsu JB; Gerner ST; Köhn J; Lücking H; Kloska SP; Huttner HB
    Cerebrovasc Dis; 2017; 43(3-4):117-123. PubMed ID: 28049189
    [TBL] [Abstract][Full Text] [Related]  

  • 114. Early edema in warfarin-related intracerebral hemorrhage.
    Levine JM; Snider R; Finkelstein D; Gurol ME; Chanderraj R; Smith EE; Greenberg SM; Rosand J
    Neurocrit Care; 2007; 7(1):58-63. PubMed ID: 17657657
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Natural course of perihemorrhagic edema after intracerebral hemorrhage.
    Staykov D; Wagner I; Volbers B; Hauer EM; Doerfler A; Schwab S; Bardutzky J
    Stroke; 2011 Sep; 42(9):2625-9. PubMed ID: 21737803
    [TBL] [Abstract][Full Text] [Related]  

  • 116. Peak perihemorrhagic edema correlates with functional outcome in intracerebral hemorrhage.
    Volbers B; Giede-Jeppe A; Gerner ST; Sembill JA; Kuramatsu JB; Lang S; Lücking H; Staykov D; Huttner HB
    Neurology; 2018 Mar; 90(12):e1005-e1012. PubMed ID: 29453243
    [TBL] [Abstract][Full Text] [Related]  

  • 117. Nuclear factor-κB activation in perihematomal brain tissue correlates with outcome in patients with intracerebral hemorrhage.
    Zhang ZL; Liu YG; Huang QB; Wang HW; Song Y; Xu ZK; Li F
    J Neuroinflammation; 2015 Mar; 12():53. PubMed ID: 25889503
    [TBL] [Abstract][Full Text] [Related]  

  • 118. Intraventricular fibrinolysis does not increase perihemorrhagic edema after intracerebral hemorrhage.
    Volbers B; Wagner I; Willfarth W; Doerfler A; Schwab S; Staykov D
    Stroke; 2013 Feb; 44(2):362-6. PubMed ID: 23306318
    [TBL] [Abstract][Full Text] [Related]  

  • 119. Intracerebral hemorrhage with hypothyroidism.
    Czap A; Shoup JP; Winkler J; Staff I; Fortunato G; Malchoff C; McCullough LD; Sansing LH
    J Stroke Cerebrovasc Dis; 2013 Nov; 22(8):e602-9. PubMed ID: 24045084
    [TBL] [Abstract][Full Text] [Related]  

  • 120. Emerging tumefactive multiple sclerosis after switching therapy from natalizumab to fingolimod.
    Jander S; Turowski B; Kieseier BC; Hartung HP
    Mult Scler; 2012 Nov; 18(11):1650-2. PubMed ID: 23100527
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.